More Thyroid Cancers ID’d in Patients With No Symptoms
Forty-six percent of patients who underwent thyroid-directed surgery had cancer; of these, 51 percent were asymptomatic.
Forty-six percent of patients who underwent thyroid-directed surgery had cancer; of these, 51 percent were asymptomatic.
An analysis of studies in the literature sought to determine the financial burden patients with thyroid cancer incur from diagnosis, treatment, and surveillance.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
The risk of recurrence varied by patient age, tumor size, and number of foci.
The overall survival rate at 1 year was 86% with vandetanib and 70% with cabozantinib.
Patients with parathyroid carcinoma after localized resection for a presumed benign indication should undergo close monitoring for recurrence rather than radical surgery.
Researchers identified risk factors for distant metastasis in sporadic and hereditary medullary thyroid cancer.
The designation is supported by data from the randomized, double-blind, placebo-controlled phase 3 COSMIC-311 study.
Investigators tested the hypothesis that greater exposure to light at night (LAN) is associated with an increased risk for thyroid cancer by studying artificial outdoor LAN measured by satellite imagery in relation to thyroid cancer.
Positive association mainly driven by incidence of papillary thyroid cancer.